-
1
-
-
0036157811
-
Misoprostol for women's health: A review
-
Blanchard K, Clark S, Winikoff B, Gaines G, Kabani G, Shannon C. Misoprostol for women's health: a review. Obstet Gynecol. 2002;99:316-32.
-
(2002)
Obstet Gynecol
, vol.99
, pp. 316-332
-
-
Blanchard, K.1
Clark, S.2
Winikoff, B.3
Gaines, G.4
Kabani, G.5
Shannon, C.6
-
2
-
-
0037380040
-
Gemeprost versus misoprostol for cervical priming before first-trimester abortion: A randomized controlled trial
-
Ekerhovd E, Radulovic N, Norström A. Gemeprost versus misoprostol for cervical priming before first-trimester abortion: a randomized controlled trial. Obstet Gynecol. 2003;101:722-5.
-
(2003)
Obstet Gynecol
, vol.101
, pp. 722-725
-
-
Ekerhovd, E.1
Radulovic, N.2
Norström, A.3
-
3
-
-
0032984320
-
Vaginal misoprostol for pre-induction cervical priming: Is there an optimal evacuation time interval?
-
Singh K, Fong YF, Prasad RNV, Dong F. Vaginal misoprostol for pre-induction cervical priming: is there an optimal evacuation time interval? Br J Obstet Gynaecol. 1997;106:266-9.
-
(1997)
Br J Obstet Gynaecol
, vol.106
, pp. 266-269
-
-
Singh, K.1
Fong, Y.F.2
Prasad, R.N.V.3
Dong, F.4
-
4
-
-
0030799375
-
Nitric oxide donors induce ripening of the human uterine cervix: A randomised controlled trial
-
Thomson AJ, Lunan CB, Cameron AD, Cameron IT, Greer IA, Norman JE. Nitric oxide donors induce ripening of the human uterine cervix: a randomised controlled trial. Br J Obstet Gynecol. 1997;104:1054-7.
-
(1997)
Br J Obstet Gynecol
, vol.104
, pp. 1054-1057
-
-
Thomson, A.J.1
Lunan, C.B.2
Cameron, A.D.3
Cameron, I.T.4
Greer, I.A.5
Norman, J.E.6
-
5
-
-
0032480544
-
Randomised trial of nitric oxide donor versus prostaglandin for cervical ripening before first-trimester termination of pregnancy
-
Thomson AJ, Lunan CB, Ledingham M, Howat RC, Cameron IT, Greer IA, et al. Randomised trial of nitric oxide donor versus prostaglandin for cervical ripening before first-trimester termination of pregnancy. Lancet. 1998;352:1093-6.
-
(1998)
Lancet
, vol.352
, pp. 1093-1096
-
-
Thomson, A.J.1
Lunan, C.B.2
Ledingham, M.3
Howat, R.C.4
Cameron, I.T.5
Greer, I.A.6
-
6
-
-
0033776215
-
Chemical ripening of the cervix with intracervical application of sodium nitroprusside: A randomised controlled trial
-
Facchinetti F, Piccinini F, Volpe A. Chemical ripening of the cervix with intracervical application of sodium nitroprusside: a randomised controlled trial. Hum Reprod. 2000;15:2224-7.
-
(2000)
Hum Reprod
, vol.15
, pp. 2224-2227
-
-
Facchinetti, F.1
Piccinini, F.2
Volpe, A.3
-
7
-
-
0035857966
-
The CONSORT Statement: Revised recommendations for improving the quality of reports of parallel-group randomised trials
-
CONSORT Group
-
CONSORT Group. The CONSORT Statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet. 2001;357:1191-4.
-
(2001)
Lancet
, vol.357
, pp. 1191-1194
-
-
-
8
-
-
0019592009
-
Use of a force measuring instrument during cervical dilatation
-
Fisher J, Anthony GS, McManus TJ, Coutts JR, Calder AA. Use of a force measuring instrument during cervical dilatation. J Med Eng Technol. 1981;5:194-5.
-
(1981)
J Med Eng Technol
, vol.5
, pp. 194-195
-
-
Fisher, J.1
Anthony, G.S.2
McManus, T.J.3
Coutts, J.R.4
Calder, A.A.5
-
9
-
-
0026070110
-
Pre-operative cervical preparation before first trimester vacuum aspiration: A randomized controlled comparison between gemeprost and mifepristone (RU 486)
-
Henshaw RC, Templeton AA. Pre-operative cervical preparation before first trimester vacuum aspiration: a randomized controlled comparison between gemeprost and mifepristone (RU 486). Br J Obstet Gynaecol. 1991;98:1025-30.
-
(1991)
Br J Obstet Gynaecol
, vol.98
, pp. 1025-1030
-
-
Henshaw, R.C.1
Templeton, A.A.2
-
10
-
-
0031808966
-
A comparative study using two dose regimens (200 μg or 400 μg) of vaginal misoprostol for pre-operative cervical dilatation in first trimester nulliparae
-
Fong YF, Singh K, Prasad RNV. A comparative study using two dose regimens (200 μg or 400 μg) of vaginal misoprostol for pre-operative cervical dilatation in first trimester nulliparae. Br J Obstet Gynaecol. 1998;105:413-7.
-
(1998)
Br J Obstet Gynaecol
, vol.105
, pp. 413-417
-
-
Fong, Y.F.1
Singh, K.2
Prasad, R.N.V.3
-
11
-
-
0025286693
-
Complications of first-trimester abortion: A report of 170,000 cases
-
Hakim-Elahi E, Tovell HM, Burnhill MS. Complications of first-trimester abortion: a report of 170,000 cases. Obstet Gynecol. 1990;76:129-35.
-
(1990)
Obstet Gynecol
, vol.76
, pp. 129-135
-
-
Hakim-Elahi, E.1
Tovell, H.M.2
Burnhill, M.S.3
-
13
-
-
7044261230
-
The Care of Women Requesting Induced Abortion
-
Royal College of Obstetricians and Gynaecologists, London: RCOG Press;
-
Royal College of Obstetricians and Gynaecologists. The Care of Women Requesting Induced Abortion. Evidence-based Clinical Guideline Number 7. London: RCOG Press; 2004.
-
(2004)
Evidence-based Clinical Guideline
, Issue.7
-
-
-
14
-
-
0031792891
-
Randomized trial to determine optimal dose of vaginal misoprostol for preabortion cervical priming
-
Singh K, Fong YF, Prasad RNV, Dong F. Randomized trial to determine optimal dose of vaginal misoprostol for preabortion cervical priming. Obstet Gynecol. 1998;5:795-8.
-
(1998)
Obstet Gynecol
, vol.5
, pp. 795-798
-
-
Singh, K.1
Fong, Y.F.2
Prasad, R.N.V.3
Dong, F.4
-
15
-
-
0141990495
-
A comparison of isosorbide mononitrate and misoprostol cervical ripening before suction evacuation
-
Li CFI, Chan CWC, Ho PC. A comparison of isosorbide mononitrate and misoprostol cervical ripening before suction evacuation. Obstet Gynecol. 2003;102:583-8.
-
(2003)
Obstet Gynecol
, vol.102
, pp. 583-588
-
-
Li, C.F.I.1
Chan, C.W.C.2
Ho, P.C.3
-
16
-
-
0026716853
-
Pharmacokinetics of isosorbide mononitrate
-
Abshagen U. Pharmacokinetics of isosorbide mononitrate. Am J Cardiol. 1992;70:61G-6G.
-
(1992)
Am J Cardiol
, vol.70
-
-
Abshagen, U.1
-
17
-
-
0037219534
-
Serum profile of isosorbide mononitrate after vaginal administration in the third trimester
-
Bates CD, Nicoll AE, Mullen AB, Mackenzie F, Thomson AJ, Norman JE. Serum profile of isosorbide mononitrate after vaginal administration in the third trimester. BJOG. 2003;110:64-7.
-
(2003)
BJOG
, vol.110
, pp. 64-67
-
-
Bates, C.D.1
Nicoll, A.E.2
Mullen, A.B.3
Mackenzie, F.4
Thomson, A.J.5
Norman, J.E.6
|